These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28834196)

  • 1. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.
    Martorell L; Luce E; Vazquez JL; Richaud-Patin Y; Jimenez-Delgado S; Corrales I; Borras N; Casacuberta-Serra S; Weber A; Parra R; Altisent C; Follenzi A; Dubart-Kupperschmitt A; Raya A; Vidal F; Barquinero J
    J Thromb Haemost; 2017 Nov; 15(11):2188-2197. PubMed ID: 28834196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.
    Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F
    Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
    Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
    Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations.
    Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C＞T(p.R75X).
    Ma Y; Sun W; Liu X; Ren J; Zhang X; Zhang R; Zhao L; Yang L; Wang G
    Stem Cell Res; 2022 Apr; 60():102684. PubMed ID: 35121195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.
    Krooss S; Werwitzke S; Kopp J; Rovai A; Varnholt D; Wachs AS; Goyenvalle A; Aarstma-Rus A; Ott M; Tiede A; Langemeier J; Bohne J
    PLoS Genet; 2020 Apr; 16(4):e1008690. PubMed ID: 32267853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The State of Skewed X Chromosome Inactivation is Retained in the Induced Pluripotent Stem Cells from a Female with Hemophilia B.
    Lyu C; Shen J; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang D; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cells Dev; 2017 Jul; 26(13):1003-1011. PubMed ID: 28401797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees.
    Lu Y; Wu X; Dai J; Ding Q; Wu W; Wang X
    Haemophilia; 2019 Mar; 25(2):316-323. PubMed ID: 30648777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology.
    Ma Y; Sun W; Zhao L; Yao M; Wu C; Su P; Yang L; Wang G
    Stem Cell Res Ther; 2022 Jul; 13(1):353. PubMed ID: 35883203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype analysis identifies the cause of the "royal disease".
    Rogaev EI; Grigorenko AP; Faskhutdinova G; Kittler EL; Moliaka YK
    Science; 2009 Nov; 326(5954):817. PubMed ID: 19815722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.
    Bastida JM; González-Porras JR; Jiménez C; Benito R; Ordoñez GR; Álvarez-Román MT; Fontecha ME; Janusz K; Castillo D; Fisac RM; García-Frade LJ; Aguilar C; Martínez MP; Bermejo N; Herrero S; Balanzategui A; Martin-Antorán JM; Ramos R; Cebeiro MJ; Pardal E; Aguilera C; Pérez-Gutierrez B; Prieto M; Riesco S; Mendoza MC; Benito A; Hortal Benito-Sendin A; Jiménez-Yuste V; Hernández-Rivas JM; García-Sanz R; González-Díaz M; Sarasquete ME
    Thromb Haemost; 2017 Jan; 117(1):66-74. PubMed ID: 27734074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B.
    Nakamura Y; Murata M; Takagi Y; Kozuka T; Nakata Y; Hasebe R; Takagi A; Kitazawa J; Shima M; Kojima T
    Int J Hematol; 2015 Jul; 102(1):134-9. PubMed ID: 25739383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 14 F9 synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression.
    Zhang H; Chen C; Wu X; Lou C; Liang Q; Wu W; Wang X; Ding Q
    Hum Mutat; 2022 Jul; 43(7):928-939. PubMed ID: 35391506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing nonsense-mediated mRNA decay.
    Wang G; Chai B; Yang L
    Biomed Pharmacother; 2016 May; 80():331-337. PubMed ID: 27133073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells.
    He Q; Wang HH; Cheng T; Yuan WP; Ma YP; Jiang YP; Ren ZH
    Chin Med Sci J; 2017 Sep; 32(3):135-144. PubMed ID: 28956740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Mediated In Situ Introduction or Integration of
    Tang Q; Hu Z; Zhao J; Zhou T; Tang S; Wang P; Xiao R; Chen Y; Wu L; Zhou M; Liang D
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX.
    Ramaswamy S; Tonnu N; Menon T; Lewis BM; Green KT; Wampler D; Monahan PE; Verma IM
    Cell Rep; 2018 May; 23(5):1565-1580. PubMed ID: 29719266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Altered Splicing in Stable Cell Strains Expressing Mini-hF9 Gene with Nonsense Mutation].
    Wang G; Sun WW; Zhu LK; Ma YC; Zhang XL; Zhang JH; Ren J; Qin XY; Yang LH; Chai BF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):228-232. PubMed ID: 33554825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.